2019
May
03
Stay Connected
Subscribe to our mailing list to receive CFAR-related news, events, and funding opportunities.
Harvard CFAR Twitter Feed
-
Dolutegravir-Based Strategies Offer Benefits for Women With HIV t.co/rQSEibiBNp
-
According to a @NIH-funded clinical trial, 86% of people who received #HIV care soon after diagnosis maintained viral suppression after 48 weeks: t.co/9AZcgbT352
-
#DYK: #CDCYRBS data can be used to identify resources that help prevent #HIV among youth? t.co/QHeaA5Flpd t.co/zMYZmAmXS8
-
Two-thirds of people who could benefit most from #PrEP are African-American or Latino, but they account for the lowest percentage of PrEP prescriptions. Learn more about PrEP and #HIV: t.co/ckNiRBmCc5 t.co/PKDgXyKfSl
Welcome
The mission of the HU CFAR is to expand, promote and facilitate collaborative innovative multidisciplinary activities in HIV/AIDS research in order to bring an end to the epidemic.
Upcoming Events
Recent News
Acknowledging the CFAR to Remain in Compliance
Please be sure to acknowledge CFAR support in order to remain in compliance with NIH policy. Acknowledgment and NIH Disclaimer was updated on 12/23/2013.